chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash papular, Rash pruritic
Clinical narrative: sore arm from elbow to shoulder; red arm from elbow to shoulder; hard, swollen, sore arm; hard, swollen, sore arm; red, itchy rash; raised white pimple-like; red, itchy rash; giant rash on arm; rash under bandage; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm from elbow to shoulder), ERYTHEMA (red arm from elbow to shoulder), PERIPHERAL SWELLING (hard, swollen, sore arm), INDURATION (hard, swollen, sore arm) and ERYTHEMA (red, itchy rash) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Asthma since an unknown date and Allergy since an unknown date.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm from elbow to shoulder), ERYTHEMA (red arm from elbow to shoulder), PERIPHERAL SWELLING (hard, swollen, sore arm), INDURATION (hard, swollen, sore arm), ERYTHEMA (red, itchy rash), RASH PAPULAR (raised white pimple-like), RASH PRURITIC (red, itchy rash), INJECTION SITE RASH (giant rash on arm) and RASH (rash under bandage). The patient was treated with BETAMETHASONE (topical) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore arm from elbow to shoulder), ERYTHEMA (red arm from elbow to shoulder), PERIPHERAL SWELLING (hard, swollen, sore arm), INDURATION (hard, swollen, sore arm), ERYTHEMA (red, itchy rash), RASH PAPULAR (raised white pimple-like), RASH PRURITIC (red, itchy rash), INJECTION SITE RASH (giant rash on arm) and RASH (rash under bandage) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications include asthma medications, allergy medications and immunosupressants. Additional treatment medications include steroid cream and cold pack.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Dizziness, Headache, Injection site pain
Clinical narrative: Rash on her cheek; Dizziness; Joint pain; Chills; Headaches; Soreness at injection site; Muscle aches; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), ARTHRALGIA (Joint pain), CHILLS (Chills), HEADACHE (Headaches) and INJECTION SITE PAIN (Soreness at injection site) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (she was tested positive for COVID-19 on 10 Nov 2020 and was hospitalized from November 10-19, 2020.) on 10-Nov-2020.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced DIZZINESS (Dizziness), ARTHRALGIA (Joint pain), CHILLS (Chills), HEADACHE (Headaches), INJECTION SITE PAIN (Soreness at injection site), MYALGIA (Muscle aches) and NAUSEA (Nausea). On an unknown date, the patient experienced RASH (Rash on her cheek). At the time of the report, DIZZINESS (Dizziness), ARTHRALGIA (Joint pain), CHILLS (Chills), HEADACHE (Headaches), INJECTION SITE PAIN (Soreness at injection site), MYALGIA (Muscle aches), NAUSEA (Nausea) and RASH (Rash on her cheek) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment Not provided.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Rash
Clinical narrative: Rash on her cheek; Dizziness; Joint pain; Chills; Headaches; Soreness at injection site; Muscle aches; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), ARTHRALGIA (Joint pain), CHILLS (Chills), HEADACHE (Headaches) and INJECTION SITE PAIN (Soreness at injection site) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (she was tested positive for COVID-19 on 10 Nov 2020 and was hospitalized from November 10-19, 2020.) on 10-Nov-2020.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced DIZZINESS (Dizziness), ARTHRALGIA (Joint pain), CHILLS (Chills), HEADACHE (Headaches), INJECTION SITE PAIN (Soreness at injection site), MYALGIA (Muscle aches) and NAUSEA (Nausea). On an unknown date, the patient experienced RASH (Rash on her cheek). At the time of the report, DIZZINESS (Dizziness), ARTHRALGIA (Joint pain), CHILLS (Chills), HEADACHE (Headaches), INJECTION SITE PAIN (Soreness at injection site), MYALGIA (Muscle aches), NAUSEA (Nausea) and RASH (Rash on her cheek) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment Not provided.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 02-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were provided. No treatment information provided
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pruritus, Vaccination site erythema
Clinical narrative: The upper arm is itchy; Soreness in the arm; a red area which became larger; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (The upper arm is itchy), PAIN IN EXTREMITY (Soreness in the arm) and VACCINATION SITE ERYTHEMA (a red area which became larger) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006MR0A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced PRURITUS (The upper arm is itchy), PAIN IN EXTREMITY (Soreness in the arm) and VACCINATION SITE ERYTHEMA (a red area which became larger). At the time of the report, PRURITUS (The upper arm is itchy), PAIN IN EXTREMITY (Soreness in the arm) and VACCINATION SITE ERYTHEMA (a red area which became larger) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Accidental underdose, Vaccination site erythema, Vaccination site pain
Clinical narrative: some of it leaked on their arm/Not able to know how much of the vaccine she received; injection site hurt a little/arm a little sore; pink zone at the injection site that is the size of a quarter; This spontaneous case was reported by a consumer and describes the occurrence of ACCIDENTAL UNDERDOSE (some of it leaked on their arm/Not able to know how much of the vaccine she received), VACCINATION SITE PAIN (injection site hurt a little/arm a little sore) and VACCINATION SITE ERYTHEMA (pink zone at the injection site that is the size of a quarter) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history was reported).   On 25-Feb-2021 at 9:20 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced ACCIDENTAL UNDERDOSE (some of it leaked on their arm/Not able to know how much of the vaccine she received), VACCINATION SITE PAIN (injection site hurt a little/arm a little sore) and VACCINATION SITE ERYTHEMA (pink zone at the injection site that is the size of a quarter). On 25-Feb-2021, ACCIDENTAL UNDERDOSE (some of it leaked on their arm/Not able to know how much of the vaccine she received) had resolved. At the time of the report, VACCINATION SITE PAIN (injection site hurt a little/arm a little sore) and VACCINATION SITE ERYTHEMA (pink zone at the injection site that is the size of a quarter) outcome was unknown.            This report refers to a case of accidental underdose for mRNA-1273, lot # 010A21A  with associated AEs vaccination site pain and vaccination site erythema.; Sender's Comments: This report refers to a case of accidental underdose for mRNA-1273, lot # 010A21A  with associated AEs vaccination site pain and vaccination site erythema.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Skin reaction
Clinical narrative: Delayed reaction; This spontaneous case was reported by a physician and describes the occurrence of SKIN REACTION (Delayed reaction) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced SKIN REACTION (Delayed reaction). At the time of the report, SKIN REACTION (Delayed reaction) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided No treatment information provided
Sex: M
Vaccine: COVID19
Symptoms: Cyst
Clinical narrative: he had a painful and swollen lump in his lower back; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CYST (he had a painful and swollen lump in his lower back) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced CYST (he had a painful and swollen lump in his lower back). The patient was treated with DOXYCYCLINE at an unspecified dose and frequency. At the time of the report, CYST (he had a painful and swollen lump in his lower back) outcome was unknown.            No concomitant medications were provided
Sex: F
Vaccine: COVID19
Symptoms: Animal bite
Clinical narrative: Patient was bitten by a dog after she received the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of ANIMAL BITE (Patient was bitten by a dog after she received the vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Hernia. Concomitant products included DOXYCYCLINE for an unknown indication.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ANIMAL BITE (Patient was bitten by a dog after she received the vaccine). At the time of the report, ANIMAL BITE (Patient was bitten by a dog after she received the vaccine) outcome was unknown.            No concomitant medication information was provided. No treatment medication were provided.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jul-2021: Follow-up information received on 08-Jul-2021 contains no new information.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Hypoaesthesia oral
Clinical narrative: her cheek and her lip numb; her cheek and her lip numb; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA ORAL (her cheek and her lip numb) and HYPOAESTHESIA (her cheek and her lip numb) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced HYPOAESTHESIA ORAL (her cheek and her lip numb) and HYPOAESTHESIA (her cheek and her lip numb). At the time of the report, HYPOAESTHESIA ORAL (her cheek and her lip numb) and HYPOAESTHESIA (her cheek and her lip numb) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Vision blurred
Clinical narrative: Vision was blurred; Tiredness; Headache; Chills; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (Vision was blurred), FATIGUE (Tiredness), HEADACHE (Headache) and CHILLS (Chills) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced VISION BLURRED (Vision was blurred), FATIGUE (Tiredness), HEADACHE (Headache) and CHILLS (Chills). At the time of the report, VISION BLURRED (Vision was blurred), FATIGUE (Tiredness), HEADACHE (Headache) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Sex: M
Vaccine: COVID19
Symptoms: Prostatic specific antigen increased
Clinical narrative: PSA indicator very high; This spontaneous case was reported by a consumer and describes the occurrence of PROSTATIC SPECIFIC ANTIGEN INCREASED (PSA indicator very high) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Prostate cancer. Concomitant products included OLAPARIB (LYNPARZA) for an unknown indication.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced PROSTATIC SPECIFIC ANTIGEN INCREASED (PSA indicator very high). At the time of the report, PROSTATIC SPECIFIC ANTIGEN INCREASED (PSA indicator very high) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided
Sex: U
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Fatigue, Headache, Myalgia
Clinical narrative: Nausea; Diarrhea; Fever; Chills; Fatigue; Splitting headache; Muscle aches; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), PYREXIA (Fever), CHILLS (Chills), FATIGUE (Fatigue) and HEADACHE (Splitting headache) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Migraine (Years ago.).   On 23-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced VOMITING (Vomiting). On 24-Feb-2021, the patient experienced DIARRHOEA (Diarrhea), PYREXIA (Fever), CHILLS (Chills), FATIGUE (Fatigue), HEADACHE (Splitting headache) and MYALGIA (Muscle aches). On 25-Feb-2021, the patient experienced NAUSEA (Nausea). At the time of the report, DIARRHOEA (Diarrhea), PYREXIA (Fever), CHILLS (Chills), MYALGIA (Muscle aches) and VOMITING (Vomiting) outcome was unknown and FATIGUE (Fatigue), HEADACHE (Splitting headache) and NAUSEA (Nausea) had not resolved.            Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, Vomiting
Clinical narrative: Nausea; Diarrhea; Fever; Chills; Fatigue; Splitting headache; Muscle aches; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), PYREXIA (Fever), CHILLS (Chills), FATIGUE (Fatigue) and HEADACHE (Splitting headache) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Migraine (Years ago.).   On 23-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced VOMITING (Vomiting). On 24-Feb-2021, the patient experienced DIARRHOEA (Diarrhea), PYREXIA (Fever), CHILLS (Chills), FATIGUE (Fatigue), HEADACHE (Splitting headache) and MYALGIA (Muscle aches). On 25-Feb-2021, the patient experienced NAUSEA (Nausea). At the time of the report, DIARRHOEA (Diarrhea), PYREXIA (Fever), CHILLS (Chills), MYALGIA (Muscle aches) and VOMITING (Vomiting) outcome was unknown and FATIGUE (Fatigue), HEADACHE (Splitting headache) and NAUSEA (Nausea) had not resolved.            Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Hypersomnia, Pain, Pruritus, Rash, Urticaria
Clinical narrative: Sleeping pretty much since she had the vaccine/ exhaustion; Pain and aches in her neck, shoulders, spine, and hips; Hives; Itching; Rash; Reaction site was red; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSOMNIA (Sleeping pretty much since she had the vaccine/ exhaustion), PAIN (Pain and aches in her neck, shoulders, spine, and hips), URTICARIA (Hives), PRURITUS (Itching) and RASH (Rash) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 04-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPERSOMNIA (Sleeping pretty much since she had the vaccine/ exhaustion), PAIN (Pain and aches in her neck, shoulders, spine, and hips), URTICARIA (Hives), PRURITUS (Itching), RASH (Rash) and VACCINATION SITE ERYTHEMA (Reaction site was red). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) at an unspecified dose and frequency. At the time of the report, HYPERSOMNIA (Sleeping pretty much since she had the vaccine/ exhaustion), PAIN (Pain and aches in her neck, shoulders, spine, and hips), URTICARIA (Hives), PRURITUS (Itching), RASH (Rash) and VACCINATION SITE ERYTHEMA (Reaction site was red) outcome was unknown.            No concomitant medications were provided    This case was linked to MOD-2021-025616 (E2B Linked Report).; Sender's Comments:  MOD-2021-025616:
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: Sleeping pretty much since she had the vaccine/ exhaustion; Pain and aches in her neck, shoulders, spine, and hips; Hives; Itching; Rash; Reaction site was red; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSOMNIA (Sleeping pretty much since she had the vaccine/ exhaustion), PAIN (Pain and aches in her neck, shoulders, spine, and hips), URTICARIA (Hives), PRURITUS (Itching) and RASH (Rash) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 04-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPERSOMNIA (Sleeping pretty much since she had the vaccine/ exhaustion), PAIN (Pain and aches in her neck, shoulders, spine, and hips), URTICARIA (Hives), PRURITUS (Itching), RASH (Rash) and VACCINATION SITE ERYTHEMA (Reaction site was red). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) at an unspecified dose and frequency. At the time of the report, HYPERSOMNIA (Sleeping pretty much since she had the vaccine/ exhaustion), PAIN (Pain and aches in her neck, shoulders, spine, and hips), URTICARIA (Hives), PRURITUS (Itching), RASH (Rash) and VACCINATION SITE ERYTHEMA (Reaction site was red) outcome was unknown.            No concomitant medications were provided    This case was linked to MOD-2021-025616 (E2B Linked Report).; Sender's Comments:  MOD-2021-025616:
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Pain, Pain in extremity, Pyrexia
Clinical narrative: Body ache; Sore arm, Pain in the legs; Pain in the hips; Slight fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body ache), PAIN IN EXTREMITY (Sore arm, Pain in the legs), ARTHRALGIA (Pain in the hips) and PYREXIA (Slight fever) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.  Concomitant products included OMEPRAZOLE for an unknown indication.  On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (Body ache), PAIN IN EXTREMITY (Sore arm, Pain in the legs), ARTHRALGIA (Pain in the hips) and PYREXIA (Slight fever). At the time of the report, PAIN (Body ache), PAIN IN EXTREMITY (Sore arm, Pain in the legs), ARTHRALGIA (Pain in the hips) and PYREXIA (Slight fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headache from hell; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache from hell) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 012M20A) for COVID-19 vaccination.     Concomitant products included VORTIOXETINE HYDROBROMIDE (TRINTELLIX) for Antidepressant drug clearance NOS, BUTALBITAL for Headache.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced HEADACHE (headache from hell). At the time of the report, HEADACHE (headache from hell) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 25-Feb-2021: follow up added
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site oedema
Clinical narrative: fluid in her arm; deep, deep redness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE OEDEMA (fluid in her arm) and VACCINATION SITE ERYTHEMA (deep, deep redness) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced VACCINATION SITE OEDEMA (fluid in her arm) and VACCINATION SITE ERYTHEMA (deep, deep redness). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Redness, at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Oedema, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE OEDEMA (fluid in her arm) and VACCINATION SITE ERYTHEMA (deep, deep redness) outcome was unknown.            No concomitant medication reported.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Vaccination site pain
Clinical narrative: Bitter taste in her mouth; Pain in the arm of the injection; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (Bitter taste in her mouth) and VACCINATION SITE PAIN (Pain in the arm of the injection) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced DYSGEUSIA (Bitter taste in her mouth) and VACCINATION SITE PAIN (Pain in the arm of the injection). At the time of the report, DYSGEUSIA (Bitter taste in her mouth) and VACCINATION SITE PAIN (Pain in the arm of the injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications reported included blood thinner Treatment details included ice pack on injection arm.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling, Pruritus, Rash, Urinary tract infection
Clinical narrative: arm is Itchy; Arm is Hurting; Big pink large area like a circle about 3 inch and also extends inside of the arm, also thinks has fluid inside the pink big area; Area is swollen; She got Urinary tract Infection; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of URINARY TRACT INFECTION (She got Urinary tract Infection), PRURITUS (arm is Itchy), PAIN IN EXTREMITY (Arm is Hurting), RASH (Big pink large area like a circle about 3 inch and also extends inside of the arm, also thinks has fluid inside the pink big area) and PERIPHERAL SWELLING (Area is swollen) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Diabetic (Patient on diabetic medications), Anxiety (Patient on anxiety medications), Depression (Patient on depression medications) and Heart failure (Patient on heart medications).    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced URINARY TRACT INFECTION (She got Urinary tract Infection). On 24-Feb-2021, the patient experienced PRURITUS (arm is Itchy), PAIN IN EXTREMITY (Arm is Hurting), RASH (Big pink large area like a circle about 3 inch and also extends inside of the arm, also thinks has fluid inside the pink big area) and PERIPHERAL SWELLING (Area is swollen). At the time of the report, URINARY TRACT INFECTION (She got Urinary tract Infection), PRURITUS (arm is Itchy), PAIN IN EXTREMITY (Arm is Hurting), RASH (Big pink large area like a circle about 3 inch and also extends inside of the arm, also thinks has fluid inside the pink big area) and PERIPHERAL SWELLING (Area is swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: passed 42 days for 2nd dose after 1st dose; A spontaneous report, was received from a consumer concerning a 62-year-old male patient, unknown race and ethnicity, who was administered Moderna's COVID-19 vaccine and had Inappropriate schedule of vaccine administered.  The patient's medical history was not provided. No relevant concomitant medications were reported. No information on allergies were provided. The reported stated that the patient was physically and mentally healthy before vaccination.  On 13 Jan 2021, the patient got the first dose of mRNA-1273 (Lot number: Unknown) via unknown route at left arm location for prophylaxis of COVID-19 infection.  On 25 Feb 2021 patient contacted and stated that he passed 42 days for his second dose of vaccination which was on 10 Feb 2021 got delayed due to  storm and he didn't receive a call to get his 2nd dose .  On unknown date  patient experienced Inappropriate schedule of vaccine administered.  Action taken for the Inappropriate schedule of vaccine administered was unknown  The outcome for  Inappropriate schedule of vaccine administered was considered as recovered.; Reporter's Comments: This report refers to a case of inappropriate schedule of product administration for mRNA-1273, lot # unknown, with no associated AEs.
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (diarrhea). At the time of the report, DIARRHOEA (diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Periarthritis
Clinical narrative: Minor case of Shingles; Frozen Shoulder; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Minor case of Shingles) and PERIARTHRITIS (Frozen Shoulder) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (Minor case of Shingles) and PERIARTHRITIS (Frozen Shoulder). At the time of the report, HERPES ZOSTER (Minor case of Shingles) and PERIARTHRITIS (Frozen Shoulder) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 25-Feb-2021: follow up added On 12-May-2021: ADR
Sex: U
Vaccine: COVID19
Symptoms: Asthenia, Chills, Fatigue, Hot flush, Pain in extremity
Clinical narrative: Sore arm; Body weakness; Hot flashes; Fatigue; Chills; This spontaneous case was reported by a health care professional and describes the occurrence of PAIN IN EXTREMITY (Sore arm), ASTHENIA (Body weakness), HOT FLUSH (Hot flashes), FATIGUE (Fatigue) and CHILLS (Chills) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm), ASTHENIA (Body weakness), HOT FLUSH (Hot flashes), FATIGUE (Fatigue) and CHILLS (Chills). At the time of the report, PAIN IN EXTREMITY (Sore arm), ASTHENIA (Body weakness), HOT FLUSH (Hot flashes) and FATIGUE (Fatigue) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided No treatment information provided    This case was linked to MOD-2021-026552 (Patient Link).
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Lip swelling, Vaccination site dysaesthesia
Clinical narrative: swelling on her lower lip; felt uncomfortable; This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (swelling on her lower lip) and VACCINATION SITE DYSAESTHESIA (felt uncomfortable) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     Concomitant products included MELOXICAM and IBUPROFEN for Pain.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LIP SWELLING (swelling on her lower lip) and VACCINATION SITE DYSAESTHESIA (felt uncomfortable). The patient was treated with PARAFFIN (PETROLEUM JELLY) at an unspecified dose and frequency. At the time of the report, LIP SWELLING (swelling on her lower lip) and VACCINATION SITE DYSAESTHESIA (felt uncomfortable) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: U
Vaccine: COVID19
Symptoms: Medication error
Clinical narrative: Near miss of potentially administering a Moderna COVID-19 vaccine to an acutely ill patient; A spontaneous report  was received from a Healthcare Professional concerning a  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and for reported near miss of potentially administering a moderna covid-19 vaccine to an acutely ill patient.  The patient's medical history included fatigue, does not look well, nausea and a headache. No relevant concomitant medications were reported.  On unknown date, prior to the onset of the events the patient did not receive their planned doses of mRNA-1273 (lot/batch: Detail Batch Number) via unknown route for prophylaxis of COVID-19 infection.  On 15 Jan 2021, the healthcare professional wanted to know if a staff member who was experiencing fatigue, does not look well, nausea and a headache, should get vaccinated (medication error).  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   On an unknown date the outcome of event was recovered.; Sender's Comments: This case refers to a HCP who called to enquire if a ill staff member should get vaccinated. No record that they were vaccinated and there is no reported AEs.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Nausea, Toothache
Clinical narrative: Migraine behind the eyes; Pain in the teeth; nausea; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Migraine behind the eyes), TOOTHACHE (Pain in the teeth) and NAUSEA (nausea) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Allergic reaction.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced MIGRAINE (Migraine behind the eyes), TOOTHACHE (Pain in the teeth) and NAUSEA (nausea). At the time of the report, MIGRAINE (Migraine behind the eyes), TOOTHACHE (Pain in the teeth) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment include Tylenol.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Influenza like illness, Pain in extremity, Respiration abnormal
Clinical narrative: felt bad; breathing problems; fatigue; flu like sympotoms; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt bad), RESPIRATION ABNORMAL (breathing problems), INFLUENZA LIKE ILLNESS (flu like sympotoms), PAIN IN EXTREMITY (sore arm) and FATIGUE (fatigue) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030MZ0A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 14-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like sympotoms). On 16-Feb-2021, the patient experienced RESPIRATION ABNORMAL (breathing problems) and FATIGUE (fatigue). On 21-Feb-2021, the patient experienced FEELING ABNORMAL (felt bad). At the time of the report, FEELING ABNORMAL (felt bad), RESPIRATION ABNORMAL (breathing problems), INFLUENZA LIKE ILLNESS (flu like sympotoms), PAIN IN EXTREMITY (sore arm) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment medication reported.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Lymph node pain, Malaise, Nausea
Clinical narrative: felt very sick; lymph nodes in right arm pit very sore; chills; terrible nausea; bad headache; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (felt very sick), LYMPH NODE PAIN (lymph nodes in right arm pit very sore), CHILLS (chills), NAUSEA (terrible nausea) and HEADACHE (bad headache) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MALAISE (felt very sick), LYMPH NODE PAIN (lymph nodes in right arm pit very sore), CHILLS (chills), NAUSEA (terrible nausea) and HEADACHE (bad headache). At the time of the report, MALAISE (felt very sick), LYMPH NODE PAIN (lymph nodes in right arm pit very sore), CHILLS (chills), NAUSEA (terrible nausea) and HEADACHE (bad headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Dermatitis acneiform
Clinical narrative: broke out around neck, on breasts and underneath breasts; This spontaneous case was reported by a consumer and describes the occurrence of DERMATITIS ACNEIFORM (broke out around neck, on breasts and underneath breasts) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     The patient's past medical history included Rash. Concomitant products included SIMVASTATIN, ACETYLSALICYLIC ACID (BABY ASPIRIN), FISH OIL, VITAMIN D NOS and CEFALEXIN (KEFLEX [CEFALEXIN]) for an unknown indication.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced DERMATITIS ACNEIFORM (broke out around neck, on breasts and underneath breasts). At the time of the report, DERMATITIS ACNEIFORM (broke out around neck, on breasts and underneath breasts) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Swelling
Clinical narrative: head feels puffy; face feels kind of numb; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (head feels puffy) and HYPOAESTHESIA (face feels kind of numb) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SWELLING (head feels puffy) and HYPOAESTHESIA (face feels kind of numb). At the time of the report, SWELLING (head feels puffy) and HYPOAESTHESIA (face feels kind of numb) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication include cholesterol medication  No treatment information provided   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Received-Non Significant FU-Denies Further Followup
Sex: F
Vaccine: COVID19
Symptoms: Eczema, Lymphadenopathy
Clinical narrative: eczema welts; swollen lymph nodes in neck; This spontaneous case was reported by a consumer and describes the occurrence of ECZEMA (eczema welts) and LYMPHADENOPATHY (swollen lymph nodes in neck) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ECZEMA (eczema welts) and LYMPHADENOPATHY (swollen lymph nodes in neck). The patient was treated with FEXOFENADINE HYDROCHLORIDE (ALLEGRA) at a dose of UNK dosage form. At the time of the report, ECZEMA (eczema welts) and LYMPHADENOPATHY (swollen lymph nodes in neck) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.; Reporter's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Feeling abnormal, Headache, Malaise, Musculoskeletal discomfort
Clinical narrative: neck hurt; feel like she is going to floor up; everything hurts; felt so weak; felling awful; all her body hurts; headache; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL DISCOMFORT (neck hurt), FEELING ABNORMAL (feel like she is going to floor up), PAIN (everything hurts), ASTHENIA (felt so weak) and MALAISE (felling awful) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unk) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced MUSCULOSKELETAL DISCOMFORT (neck hurt), FEELING ABNORMAL (feel like she is going to floor up), PAIN (everything hurts), ASTHENIA (felt so weak), MALAISE (felling awful), MYALGIA (all her body hurts) and HEADACHE (headache). At the time of the report, MUSCULOSKELETAL DISCOMFORT (neck hurt), FEELING ABNORMAL (feel like she is going to floor up), PAIN (everything hurts), ASTHENIA (felt so weak), MALAISE (felling awful), MYALGIA (all her body hurts) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain
Clinical narrative: neck hurt; feel like she is going to floor up; everything hurts; felt so weak; felling awful; all her body hurts; headache; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL DISCOMFORT (neck hurt), FEELING ABNORMAL (feel like she is going to floor up), PAIN (everything hurts), ASTHENIA (felt so weak) and MALAISE (felling awful) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unk) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced MUSCULOSKELETAL DISCOMFORT (neck hurt), FEELING ABNORMAL (feel like she is going to floor up), PAIN (everything hurts), ASTHENIA (felt so weak), MALAISE (felling awful), MYALGIA (all her body hurts) and HEADACHE (headache). At the time of the report, MUSCULOSKELETAL DISCOMFORT (neck hurt), FEELING ABNORMAL (feel like she is going to floor up), PAIN (everything hurts), ASTHENIA (felt so weak), MALAISE (felling awful), MYALGIA (all her body hurts) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided